In-Vitro Evaluation: General Principles

In-vitro evaluation of herbal extracts follows the same core principles as synthetic drug screening described elsewhere in pharmacological practice, but with several herbal-specific considerations. Because a crude herbal extract is a complex mixture rather than a single chemical entity, in-vitro assays must be interpreted with awareness that the observed activity may reflect synergistic interaction between multiple constituents rather than the action of any single compound, and that intrinsic extract colour or turbidity can interfere with colourimetric or fluorometric assay readouts, requiring appropriate extract-only background controls. Solvent vehicle control (typically DMSO, kept below 0.1% final concentration) and a validated positive control reference compound must be included in every assay run, and extract concentrations are typically screened across a broad range to establish a genuine dose-response relationship before an IC50 is calculated by non-linear regression.